Full Text View
Tabular View
No Study Results Posted
Related Studies
CANVAS - CANagliflozin cardioVascular Assessment Study
This study is ongoing, but not recruiting participants.
Study NCT01032629   Information provided by Janssen Research & Development, LLC

First Received on December 10, 2009.   Last Updated on June 14, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes Mellitus, Type 2
Cardiovascular Diseases
Risk Factors
Additional conditions recognized in this trial
Diabetes Mellitus
More general conditions related to this trial
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
Canagliflozin (JNJ-28431754)
Placebo
Sponsors listed in this trial
Janssen Research & Development, LLC
George Institute, Sydney, Australia


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services